small molecule drug discovery
| 3 min read
The deal reflects growing interest in covalent chemistry as a solution for “undruggable” inflammatory proteins.
| 2 min read
Breakthrough data validates capabilities of GlueSEEKER platform to identify novel induced protein-protein interactions and expand druggable space
| 4 min read
Biotech and pharma leaders reveal the neurological therapies in development that they’re most excited about.
| 4 min read
In a Phase 2b trial, Khondrion’s sonlicromanol led to significant health benefits for patients with mitochondrial disease linked to a common mutation.
Available on Demand
New chemical synthesis technologies speed up the identification and optimization of promising drug candidates.
Page 1 of 1 - 5 Total Items
